Related Experiment Video
Updated: Aug 30, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
Antibiotic-associated Vulvovaginal Candidiasis
1101 East Alexandrine, 2nd floor, Detroit, MI 48201, USA. jxu@med.wayne.edu
Abstract:
Vulvovaginal candidiasis (VVC) is one of the most common causes of vaginitis, and its incidence has increased markedly during the past three decades. The widespread overuse of antibiotics has been suggested as one of the major factors contributing to the increasing incidence of VVC. However, evidence supporting this association has been limited because few studies with rigorous scientific methodology have been conducted. Moreover, existing data regarding the risk for developing VVC after antibiotic use are conflicting. This review examines the available information in the literature regarding antibiotic-associated VVC, its incidence, and its potential mechanisms. Implications for clinical practice and research are also discussed.
Insights
Antibiotic overuse may increase vulvovaginal candidiasis (VVC) risk. This review examines the limited evidence and conflicting data on antibiotic-associated VVC, exploring its incidence and mechanisms.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Women's Health
Background:
- Vulvovaginal candidiasis (VVC) is a common cause of vaginitis with increasing incidence.
- Antibiotic overuse is a suspected contributor to rising VVC rates.
- Existing evidence linking antibiotics to VVC is limited and conflicting.
Purpose of the Study:
- To review the literature on antibiotic-associated VVC.
- To examine the incidence and potential mechanisms of VVC after antibiotic use.
- To discuss clinical and research implications.
Main Methods:
- Systematic literature review of studies on antibiotic-associated VVC.
- Analysis of incidence data and proposed pathogenic mechanisms.
- Evaluation of clinical and research findings.
Main Results:
- Evidence directly linking antibiotic use to VVC is scarce and methodologically limited.
- Conflicting data exists regarding the precise risk of developing VVC post-antibiotic treatment.
- Potential mechanisms involve disruption of the vaginal microbiome.
Conclusions:
- Further rigorous research is needed to confirm the association between antibiotics and VVC.
- Understanding the mechanisms is crucial for clinical management and prevention strategies.
- The review highlights the need for cautious antibiotic prescribing and further investigation.
Related Concept Videos
Candidiasis
Trichomoniasis
Microbiota of the Urogenital Tract
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Urinary Tract Infection II: Pathophysiology
Antifungal Agents

